Mesna

Product manufactured by Alvogen Inc.

Application Nr Approved Date Route Status External Links
ANDA206992 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mesna Injection Is Indicated As A Prophylactic Agent In Reducing The Incidence Of Ifosfamide-Induced Hemorrhagic Cystitis. Limitation Of Use : Mesna Injection Is Not Indicated To Reduce The Risk Of Hematuria Due To Other Pathological Conditions Such As Thrombocytopenia. Mesna Injection Is A Cytoprotective Agent Indicated As A Prophylactic Agent In Reducing The Incidence Of Ifosfamide-Induced Hemorrhagic Cystitis. (1) Limitation Of Use : Mesna Injection Is Not Indicated To Reduce The Risk Of Hematuria Due To Other Pathological Conditions Such As Thrombocytopenia. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mesna MESNA ZINC3831040

Comments